semaglutide news october 2025 Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" Semaglutide Market Size, Share &

For patients with less severe cognitive problems, specifically mild cognitive impairment or early-stage Alzheimer's disease, the clinical trial evidence is slightly more positive but also less reliable [11].

doi: 10.1016/S1474-4422(25)00175-9 388 LynchDRMathewsKDPerlmanSZesiewiczTSubramonySOmidvarOet al

It also slows down digestion and lowers appetite, aiding in weight loss

By mimicking a natural hormone called GLP-1, Semaglutide helps regulate appetite and food intake, reducing hunger and enhancing feelings of fullness

This article explains exactly why GLP-1 medications can trigger hair loss, who is most at risk, what the current medical literature says, and, most importantly, the full spectrum of treatment options available today, from topical and oral medications to PRP, Exosome Hair Therapy, and FUE Hair Transplant

It also remains unclear how lipid peroxidation products generated during ferroptosis impair myelin-forming capacity of oligodendrocyte precursor cells (OPCs) and worsen white-matter softening, leaving the key drivers of progressive motor dysfunction in PVL insufficiently delineated